Skip to main content

News

Stories from 2020

Trauma blood trial

Trial innovation helps recruitment

Trauma patient blood trial leads to innovation that, if proven to be successful, could be adopted across the UK.

Coronavirus trial drugs

UHB patients take part in promising coronavirus drug trial

Early results show SNG001 drug has significantly reduced the risk of COVID-19 patients developing severe disease.

COVID-19 vaccine trial

NHS service enables people to sign up for COVID-19 vaccine studies

NHS launches service to help people across the UK sign up for information on COVID-19 vaccine trials.

Illustration of the lungs

Precision medicine trial highlights need for new approach

Pioneering lung cancer study highlights important factors to consider in the next wave of precision medicine studies.

SARS-CoV-2

Key role for Birmingham in ground-breaking coronavirus long-term health impact study

Major UK research study into the long-term health impacts of COVID-19 on hospitalised patients has been launched.

Shannaz and Ahmed Bhayat

QEHB patient one of first in UK to receive COVID-19 convalescent plasma

One of the first people to receive COVID-19 convalescent plasma has spoken about their experience and urged people to donate.